8-KThe WireRed Alert
Executive Change · Shareholder Vote
Filed Mar 12, 2025 · 1y ago · Accession 0001193125-25-052940
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- 8-K
- Filing date
- Mar 12, 2025
- Report date
- Mar 12, 2025
- Document
- d347915d8k.htm
- Size
- 196 KB